חזרה לתוצאות החיפוש

Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion

חו"ל (דורש נסיעה)מגייס משתתפים

מצבים רפואיים

Atrial Fibrillation (AF) · Atrial Fibrillation (Prevention of Stroke) · Atrial Fibrillation New Onset · Non Valvular Atrial Fibrillation · Stroke (in Patients With Atrial Fibrillation) · Stroke · Thrombosis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Esbjerg Hospital - University Hospital of Southern Denmark, involving collaboration between the Unit for Thrombosis Research, Department of Clinical Diagnostics and the Department of Cardiology., Esbjerg, Region Syddanmark, Denmark

    Contact: Study coordinator (Nedim Tojaga, Medical degree and PhD-student) · nedim.tojaga@rsyd.dk · +4552752212
    Contact: Study coordinator (Axel Brandes, Medical degree and Professor) · Axel.Brandes2@rsyd.dk · +4522903487
    Contact: Principal Investigator (Nedim Tojaga, Medical degree and PhD-student)
    Axel Brandes, Medical degree and Professor (Sub-investigator)
    Anna-Marie Bloch Münster, CMO and Associate Professor (Sub-investigator)
    Else Marie Bladbjerg, Professor (Sub-investigator)
    Jeff Healey, Medical degree and Professor (Sub-investigator)
צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)